CompletedNot Applicable

GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I)

China498 participantsStarted 2024-04-30

Plain-language summary

Patients were randomly assigned to three supraglottic airway devices (SADs) groups for airway management after anesthesia induced. Fiberoptic bronchoscope (FB) guided glottic exposure grading was performed and other airway management quality was recorded.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-75 years old; * American Society of Anesthesiologists (ASA) I-III; * Body mass index (BMI)\<30Kg/m2; * Scheduled for elective breast or lower abdominal surgery with an estimated duration of less than 4 hours; * Providing written inform consent. Exclusion Criteria: * History of oropharyngeal surgery and anatomical abnormalities; * Limited movement of the cervical spine; * High risk of reflux/aspiration; * Emergency surgery; * Acute throat inflammation and upper respiratory infection; * History of chronic bronchitis or asthma; * Cognitive dysfunction and inability to communicate; * Participating in other clinical trials.

What they're measuring

Glottic exposure grading

Timeframe: From the insertion of supraglottic airway device to the end of surgery.

Trial details

NCT IDNCT06383494

SponsorZhejiang Cancer Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Anesthesia trials